Private Equity Round - Translumina Therapeutics

Private Equity Round - Translumina Therapeutics

Investment Firm

Overview

Translumina Therapeutics is a maker of cutting-edge cardiovascular medical devices.

Announced Date

Aug 27, 2019

Funding Type

Private Equity

Highlights

Location

India, Asia

Social

Investor Lead

Everstone

Everstone

Everstone is a early_stage_venture and private_equity and venture firm.

Participant Investors

1

Investor Name
Participant InvestorEverstone

Round Details and Background

Translumina Therapeutics raised $69885298 on 2019-08-27 in Private Equity Round

Translumina Therapeutics is a maker of cutting-edge cardiovascular medical devices.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 27, 2019
Private Equity Round - Translumina Therapeutics
1-69.9M

Recent Activity

There is no recent news or activity for this profile.